Definium Therapeutics, Inc. · NASDAQ:DFTX

Deep Track Capital, LP reported a 5.54% stake in Definium Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 13, 2026

Deep Track Capital, LP reported a 5.54% stake in Definium Therapeutics, Inc., 5,676,540 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).

Stake
5.54%
Shares
5,676,540
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP5.54%5,676,540
Deep Track Biotechnology Master Fund, Ltd.5.54%5,676,540
David Kroin5.54%5,676,540

Source

View original at SEC

Related